Motivation: This is motivated by the need for non-invasive, reliable diagnostic tools to effectively monitor and evaluate the progression of MAFLD and ALD, conditions that are escalating globally and can lead to HCC. Goal(s): The study aims to advance non-invasive diagnostic tools for tracking liver disease progression. Approach: We employed a 6-month dietary intervention in mice, using multiparametric MRI and 19F MRI to assess liver disease progression through detailed imaging and voxel-wise analysis. Results: The comparison of 2 different analysis showed the importance of voxel-wise analysis. Compared to an average analysis of a heterogeneous liver the voxel-wise analysis is in clear detail. Impact: This study demonstrates the potential of multiparametric and 19F MRI with PFC for non-invasive, quantitative analysis of diet-induced liver disease, revealing detailed insights into liver inflammation, fibrosis, and disease heterogeneity. This approach could inform targeted therapies and enhance translational relevance.
Samadikhah et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: